B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies

ABSTRACT DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.1.526 that is spreading at an alarming rate in the New York City area. Two versions of the variant were identified, both with the prevalent D614G mutation in the spike protein, together with four novel point mutations...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau, Takuya Tada
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology 2021-08-01
coleção:	mBio
Assuntos:	SARS-CoV-2 neutralization B.1.526 spike protein Pfizer BNT162b2 Moderna mRNA-1273
Acesso em linha:	https://journals.asm.org/doi/10.1128/mBio.01386-21
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!